J Korean Med Assoc.  2012 Dec;55(12):1226-1236. 10.5124/jkma.2012.55.12.1226.

The economic burden of stroke in 2010 in Korea

• Kim HJ
• Kim YA
• Seo HY
• Kim EJ
• Yoon SJ
• Oh IH

• KMID: 2015668
• DOI: http://doi.org/10.5124/jkma.2012.55.12.1226

Abstract

Stroke is a disease that causes a substantial economic burden. With the rapidly aging population in Korea, the prevalence of chronic diseases, including stroke, is expected to rise, along with associated health care expenditures. Therefore, we estimated the economic burden of stroke in Korea in 2010 using nationally representative data. We used a prevalence-based approach to estimate the cost of stroke by claims data from the Korean National Health Insurance. Data from the Korea Health Panel, the Korea National Statistical Office's records of causes of death, and Labor Statistics were used to calculate direct non-medical costs and indirect costs. Direct costs included direct medical costs and direct non-medical costs, and indirect costs were opportunity costs lost due to premature death and productivity loss. Total costs were estimated by adding age- and gender-specific costs. The total economic burden of stroke was $3.53 billion: $1.87 billion for hemorrhagic stroke and $1.66 billion for ischemic stroke. The direct costs were $1.74 billion and the indirect costs were $1.79 billion. By gender, males were burdened at $2.19 billion, while females bore $1.34 billion of the total burden. Stroke imposes a huge economic burden, as indicated by the fact that the costs of stroke increased by 4.4% from 2005 to 2010, and the estimated cost was 0.35% of gross domestic product. Therefore, effective prevention programs and treatments are needed to reduce the economic burden of stroke in Korea.

Keyword

Stroke; Cost of illness; Economic burden; Prevention & control

MeSH Terms

Aging
Cause of Death
Chronic Disease
Cost of Illness
Delivery of Health Care
Efficiency
Female
Gross Domestic Product
Health Expenditures
Humans
Korea
Male
Mortality, Premature
National Health Programs
Prevalence
Stroke

Reference

1. Luengo-Fernandez R, Leal J, Gray A, Petersen S, Rayner M. Cost of cardiovascular diseases in the United Kingdom. Heart. 2006. 92:1384–1389.

2. Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 2006. 27:1610–1619.

3. Statistics Korea. Report on death causes 2008. 2008. Daejeon: Statistics Korea.

4. Korea Centers for Disease Control and Prevention. The Korea National Health and Nutrition Examination Survey (KNHANES). 2005. Cheongwon: Korea Centers for Disease Control and Prevention.

5. Statistics Korea. Report on the social statistics survey 2008. 2010. Daejeon: Statistics Korea.

6. American Heart Association. Heart disease and stroke statistics: 2008 update. 2008. Dallas: American Heart Association.

7. Kang HY, Lim SJ, Suh HS, Liew D. Estimating the lifetime economic burden of stroke according to the age of onset in South Korea: a cost of illness study. BMC Public Health. 2011. 11:646.

8. Lim SJ, Kim HJ, Nam CM, Chang HS, Jang YH, Kim S, Kang HY. Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database. J Prev Med Public Health. 2009. 42:251–260.

9. Saka RO, McGuire A, Wolfe CD. Economic burden of stroke in England. 2009. London: University of London.

10. Chan B, Hayes B. Cost of stroke in Ontario, 1994/95. CMAJ. 1998. 159:S2–S8.

11. Gosman-Hedstrom G, Claesson L, Blomstrand C, Fagerberg B, Lundgren-Lindquist B. Use and cost of assistive technology the first year after stroke. A randomized controlled trial. Int J Technol Assess Health Care. 2002. 18:520–527.

12. World Health Organization. International Classification of Diseases (ICD) [Internet]. cited 2010 Nov 1. Geneva: World Health Organization;Available from: http://www.who.int/classifications/icd/en.

13. Kim SG, Hahm MI, Choi KS, Seung NY, Shin HR, Park EC. The economic burden of cancer in Korea in 2002. Eur J Cancer Care (Engl). 2008. 17:136–144.

14. Oh IH, Yoon SJ, Seo HY, Kim EJ, Kim YA. The economic burden of musculoskeletal disease in Korea: a cross sectional study. BMC Musculoskelet Disord. 2011. 12:157.

15. Kim JH, Chung JC, Kim SO. Lee SY, editor. Results of survey on medical care cost by patient. Survey in the benefit coverage rate of National Health Insurance in 2006. 2007. Seoul: National Health Insurance Corporation;111–125.

16. Korea Health Panel. Transportation cost for healthcare utilization in 2008 [Internet]. cited 2010 Nov 1. Seoul: Korea Health Panel;Available from: http://www.khp.re.kr.

17. Sarangnanum Medicare Service Association. The official average guardian cost [Internet]. cited 2010 Nov 1. [place unknown]: Sarangnanum Medicare Service Association;Available from: http://www.sarangnanum.or.kr/esnc/service.htm.

18. Kim SY, Yoon SJ, Jo MW, Kim EJ, Kim HJ, Oh IH. Economic burden of allergic rhinitis in Korea. Am J Rhinol Allergy. 2010. 24:e110–e113.

19. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 1997. 2nd ed. Toronto: Oxford University Press.

20. Ministry of Employment and Labor. Survey report on wage structure in 2007 [Internet]. cited 2010 Nov 1. Gwacheon: Ministry of Employment and Labor;Available from: http://laborstat.molab.go.kr/SurveyWH/OLAP/Analysis/stat_OLAP.jsp?tbl_id=DT_PAY0004&org_id=118&path.

21. Schmid A, Pugin J, Chevrolet JC, Marsch S, Ludwig S, Stocker R, Finnern H. Burden of illness imposed by severe sepsis in Switzerland. Swiss Med Wkly. 2004. 134:97–102.

22. Kim J, Hahm MI, Park EC, Park JH, Park JH, Kim SE, Kim SG. Economic burden of cancer in South Korea for the year 2005. J Prev Med Public Health. 2009. 42:190–198.

23. Oh MS, Yu KH, Roh JK, Lee BC. Korean Stroke Registry Study Group. Gender differences in the mortality and outcome of stroke patients in Korea. Cerebrovasc Dis. 2009. 28:427–434.

24. Glader EL, Stegmayr B, Norrving B, Terent A, Hulter-Asberg K, Wester PO, Asplund K. Riks-Stroke Collaboration. Sex differences in management and outcome after stroke: a Swedish national perspective. Stroke. 2003. 34:1970–1975.

25. Di Carlo A, Lamassa M, Baldereschi M, Pracucci G, Basile AM, Wolfe CD, Giroud M, Rudd A, Ghetti A, Inzitari D. European BIOMED Study of Stroke Care Group. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke. 2003. 34:1114–1119.

26. Reid JM, Dai D, Gubitz GJ, Kapral MK, Christian C, Phillips SJ. Gender differences in stroke examined in a 10-year cohort of patients admitted to a Canadian teaching hospital. Stroke. 2008. 39:1090–1095.

27. Han MK, Huh Y, Lee SB, Park JH, Lee JJ, Choi EA, Lim JY, Lim S, Kim KI, Park YJ, Paik NJ, Kim TK, Jang HC, Kim KW. Korean Consortium for Health and Aging Research. Prevalence of stroke and transient ischemic attack in Korean elders: findings from the Korean Longitudinal Study on Health and Aging (KLoSHA). Stroke. 2009. 40:966–969.

28. Thorngren M, Westling B. Utilization of health care resources after stroke: a population-based study of 258 hospitalized cases followed during the first year. Acta Neurol Scand. 1991. 84:303–310.

29. Hong KS. Disability-adjusted life years analysis: implications for stroke research. J Clin Neurol. 2011. 7:109–114.

30. Koh IS, Kim HC, Kwon SB, Hwang SH, Kwon KH, Kim SM, Song HK, Lee BC. The compliance of stroke patients for secondary prevention: in Seoul & Kyunggi province. J Korean Neurol Assoc. 1999. 17:472–477.